USPTO serial 79134000
AQIX
Reviewed by CopyMark Law Group
Reg. 4473215Status 709
- Filing date
- Status date
- Registration date
- Jan 28, 2014
- Examiner
- ALVAREZ, COURTNEY
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AQIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tracy Deutmeyer
Tracy Deutmeyer Fredrikson & Byron, P.A.505 East Grand Ave, Suite 200Des Moines, IA 50309UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in scientific analysis; chemicals for scientific purposes, namely, making pharmaceutical and veterinary preparations, being media for storing organs, tissue and cells; cell, bacteria and virus growth media for use with cell, bacterial and viral cultures in scientific research | SECTION 71 - CANCELLED | — |
| 005 | Solutions for medical and clinical use in supporting human and animal cells, tissue and organs; solutions for medical and clinical use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, such preservation being to preserve stem cells and their therapeutic applications; solutions for intravenous use for medical, surgical and veterinary purposes; cultures for growing cells, bacteria [ and viruses ] for medical and clinical purposes; solutions for medical and clinical use for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids; solutions for medical and clinical use for cell, organ and tissue preservation and the creation of a homeostasis to regulate the environment of cells, organs and tissues; solutions for medical and clinical use for testing drugs on ex vivo perfused human and animal cells, tissue and organs; cell, bacteria and virus growth media, storage media and transportation media for medical or clinical use for stem cell and DNA research and therapy; pharmaceutical transfer agents or components for pharmaceuticals in the form of solutions for medical use for application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation; tissue regenerative pharmaceutical preparations and solutions; stem cells for medical and veterinary purposes; clinical diagnostic preparations for medical or veterinary use; clinical medical reagents; medical diagnostic reagents for proteomic, genomic and metabolomic analysis of tissues, cells, bacteria and viruses and testing the stability of homeostasis within organs, tissues, cells, bacteria and viruses for medical use; * none of the aforesaid * being or * relating to ready-made pharmaceuticals * substances, preparations, compositions or solutions * and none of the aforesaid * being * for use in connection with the * detection or * treatment of herpes and related viral diseases *, or for use with tissue or organs infected by herpes or related viral diseases * | SECTION 7(e) - CANCELLED | — |
| 042 | [Laboratory services for analytical testing; laboratory services relating to the researching of pharmaceuticals and solutions for medical and surgical use and solutions for supporting human and animal cells, tissue and organs, solutions for use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, solutions for storing human and animal organs, tissues and cells, solutions for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids, solutions for testing drugs on human and animal cells, tissue and organs, media for stem cell and DNA research and therapy; scientific research; medical transplant research services; medical research; scientific analysis of human tissue and human serum for medical research; stem cell and DNA scientific and medical research services; chemical research and development services; chemical, medical and scientific testing and analysis for medical research purposes; testing of pharmaceutical solutions for medical research purposes; quality control services for others; clinical medical and scientific research; conducting of clinical trials for others; design and development of new technology and products for other uses in medical and veterinary fields;] Information, advisory and consultancy services relating to [ all of the aforesaid] * laboratory services for analytical testing and to scientific research * | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aqix Limited
- Other trademarks owned by Aqix Limited
- Other trademarks owned by Aqix Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named AQIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 6, 2026 | C71T | CANCELLED SECTION 71 | — |
| Oct 12, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 28, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 5, 2021 | NCP7 | NOTICE OF PARTIAL CANCELLATION SEC. 7 SURRENDER EMAILED | — |
| Feb 4, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Feb 4, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Feb 4, 2021 | C7P. | CANCELLED SEC. 7 - PARTIAL | — |
| Dec 18, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 25, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 28, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jul 28, 2020 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Jan 28, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 13, 2018 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Apr 10, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 10, 2017 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Aug 10, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 10, 2017 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jun 16, 2017 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 27, 2016 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 12, 2016 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jan 7, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 7, 2015 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 7, 2015 | PLGL | ASSIGNED TO PARALEGAL | — |
| May 7, 2015 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| May 1, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 14, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 4, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 17, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 17, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 28, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 28, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 12, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 12, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 23, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 8, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 7, 2013 | ALIE | ASSIGNED TO LIE | — |
| Sep 25, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 24, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 27, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 27, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 25, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 24, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 9, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |